MarketPeel
Insider Trading Intelligence
Pricing
…
JP

Joshua Pinto

NMRA
PRESIDENT · NEUMORA THERAPEUTICS, INC. · CIK 0001992595
FILING MIX · LIFETIME46%/54%
BUYS
16
SELLS
19
TOTAL VALUE
$1.20M
COMPANIES
1
ACTIVE SINCE
Feb 2024
HOLDINGS NOW
57,783
AVG SELL PX
$10.50
TRADE KIND
SHOWING 35 / 35
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 8 pending
Forward-return performance of every backtestable P/S trade by Joshua Pinto, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+100.00%-4.43%-0.79%-3.64%-3.34%—
14d6+100.00%-8.93%-2.65%-6.27%-5.78%—
30d6+33.33%-2.69%-0.43%-2.26%+7.56%—
60d6+33.33%-8.21%+1.11%-9.32%+1.96%—
90d6+100.00%-28.70%+5.38%-34.09%-23.69%—
180d6(1 pending)+100.00%-69.16%+8.12%-77.28%-92.30%—
1y6(1 pending)+80.00%-46.89%+15.59%-62.48%-101.28%—
2y6(6 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NMRA · 57,783 shares · as of Feb 17, 2026
0750,0001,500,0002,250,0003,000,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 16 buys / 19 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
President
5,967$3.54$21.1K57,783Feb 17, 2026Feb 19, 2026 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,200,000——1,200,000Jan 8, 2026Jan 9, 2026 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
President
223,034——0May 28, 2025May 30, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
127,448——127,448May 28, 2025May 30, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
President
127,448——0May 28, 2025May 30, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
170,000——170,000May 28, 2025May 30, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
720,084——720,084May 28, 2025May 30, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
President
3,000,000——0May 28, 2025May 30, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
270,828——270,828May 28, 2025May 30, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
President
720,084——0May 28, 2025May 30, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
President
170,000——0May 28, 2025May 30, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,000,000——3,000,000May 28, 2025May 30, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
President
270,828——0May 28, 2025May 30, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
223,034——223,034May 28, 2025May 30, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASEGRANT
Gift
13,202——152,167May 21, 2025May 23, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALEGRANT
Gift
13,202——63,750May 21, 2025May 23, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
8,048$1.67$13.5K76,952Feb 18, 2025Feb 20, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
170,000——170,000Feb 13, 2025Feb 18, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
223,034——223,034Feb 13, 2025Feb 18, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
President
720,084——0Feb 13, 2025Feb 18, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
127,448——127,448Feb 13, 2025Feb 18, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,000,000——3,000,000Feb 13, 2025Feb 18, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
President
170,000——0Feb 13, 2025Feb 18, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
President
223,034——0Feb 13, 2025Feb 18, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
President
270,828——0Feb 13, 2025Feb 18, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
720,084——720,084Feb 13, 2025Feb 18, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
President
127,448——0Feb 13, 2025Feb 18, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
270,828——270,828Feb 13, 2025Feb 18, 2025 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
15,693$11.39$178.8K138,965Aug 27, 2024Aug 27, 2024 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
31,642$11.78$372.6K154,658Aug 26, 2024Aug 26, 2024 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
24,169$11.59$280.0K186,300Aug 23, 2024Aug 26, 2024 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
28,496$11.63$331.5K210,469Aug 22, 2024Aug 26, 2024 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALEGRANT
Gift
238,965——238,965Apr 17, 2024Jun 28, 2024 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
85,000——323,965Feb 14, 2024Feb 16, 2024 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
170,000——170,000Feb 14, 2024Feb 16, 2024 ↗View →
Other insiders · NMRA
Loading peer insiders…
About this filer
CIK 0001992595
ROLE
President
PRIMARY
NMRA
COMPANIES
1
ACTIVE SINCE
Feb 2024
MARKETPEEL · /INSIDER/0001992595DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback